Furthermore, the article underscores the global benefits of AI, including enhanced collaboration with health authorities and expedited product approvals through standardized processes. It stresses the need for agility in AI adoption strategies to capitalize on emerging opportunities and maximize AI's impact by 2025. The piece concludes by noting the rapid advancements in AI, such as generative AI, and the importance of a comprehensive strategy to leverage these developments effectively.
Key takeaways:
- AI is transitioning from improving process efficiency to supporting entirely new business practices, fundamentally changing how companies operate.
- Enterprises are expected to shift from AI experimentation to reinvention by 2025, with AI becoming a core, embedded capability in business operations.
- AI's integration in life sciences R&D can transform processes like drug discovery, clinical research, and supply-chain relationships, enhancing efficiency and innovation.
- The modernization of IT infrastructures and enrichment of data, including real-world data and evidence, are crucial for maximizing AI's potential and driving additional value.